Exhibit 23.1

​

​

​

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

​

We consent to the incorporation by reference in Registration Statement No. 333-288322 on Form S-3 and Registration Statement No. 333-288520 on Form S-8 of our report dated March 31, 2026, relating to the financial statements of Brainstorm Cell Therapeutics Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2025.

​

/s/ Brightman Almagor Zohar & Co.

​

Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

Tel Aviv, Israel

March 31, 2026